NORGES BANK - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
NORGES BANK ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$19,477,210
-12.8%
498,011
+6.2%
0.01%
-16.7%
Q3 2022$22,343,541
+28.3%
469,008
+4.2%
0.01%
+20.0%
Q2 2022$17,415,203
+5.8%
449,889
+56.6%
0.01%
+25.0%
Q1 2022$16,458,623
-26.9%
287,236
+1.6%
0.00%
-20.0%
Q4 2021$22,526,000
-17.4%
282,666
-9.9%
0.01%
-16.7%
Q3 2021$27,282,000
-25.4%
313,553
+10.4%
0.01%
-25.0%
Q2 2021$36,561,000
+47.6%
284,061
-8.2%
0.01%
+33.3%
Q1 2021$24,763,000
+10527.9%
309,382
+3616.7%
0.01%
Q2 2020$233,000
-35.3%
8,324
-58.4%
0.00%
Q1 2020$360,00020,0000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders